Results 1 - 10 of 17 : 1 2 Next
Pfizer Takes the Plunge Into Stem-Cell Research
It looks like a new unit focusing on this will include work with other companies.
These were the market's biggest gainers on Monday.
The FDA moves closer to setting up stem cell clinical trials.
5 Stocks Approaching Greatness
Investors can find great investments by looking beyond the glare of the top-rated stars.
Who's fallen hardest? Who can bounce highest?
Stem Your Expectations of Stem-Cell Discoveries
Making "stem" cells out of skin cells isn't all it's cracked up to be.
Low-priced stocks: Cheap for a reason, or great opportunities?
Companies fund a stem-cell consortium to make drugs safer.
PerkinElmer and ViaCell: A Bloody Good Deal?
PerkinElmer buys ViaCell for $300 million.
The chimerical future is here.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK